TSE:4502Pharmaceuticals
Takeda (TSE:4502) Stock Struggles To Convert Revenue Growth Into Lasting Profit
The market has treated Takeda Pharmaceutical like a problem stock for months, with the share price roughly flat over three months and slightly weaker over the past week. Today's Q1 2027 earnings land as a sentiment test. Reported revenue sits at ¥1.22b and basic earnings per share for the quarter are ¥71.65, while trailing twelve month earnings still show a loss of ¥103.52 per share. The headline is simple: investors are being asked to square an improving quarterly profit picture with a...